FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Healthpeak Q1: $880m Janus Living Spinoff Unlocks Value

By

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

DOC delivered mixed Q1 2026 results with revenue up 7.1% Y/Y to $753M and rental revenue of $739M (+7.5%) exceeding consensus by $46M, though FFO per share declined to $0.45 from $0.46 but beat estimates by $0.02. The successful Janus Living IPO generated $880M in proceeds and created a $6.9B market cap senior housing platform, validating management's value unlock strategy while DOC retains 81.6% ownership. Updated 2026 guidance reflects the IPO impact, with EPS raised to $0.46-$0.50 while FFO lowered to $1.68-$1.72 due to lost management fees. Same-store NOI was flat with Senior Housing strength (+13.8%) offset by Lab struggles (-7.2%). Occupancy pressures continued with Lab down 740 bps Y/Y to 90.4% and Outpatient Medical down 70 bps to 91.8%. DOC repurchased $100M in shares. We believe Outpatient Medical occupancy will improve but see Lab vacancy rates increasing through Q3 2026. We see persistent biotech funding challenges limiting Lab upside through 1H 2027.

Related Articles

Research

Research Alert: Expd: Q1 Results Top Expectations

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:EXPD delivered strong Q1 results, with EPS of $1.71 versus $1.47 prior year, significantly beating our $1.37 estimate and $1.33 consensus forecast. Revenue rose 4% to $2.7B from $2.67B, exceeding our $2.59B forecast as Airfreight and Customs strength offset Ocean weakness. Mixed segment performance reflected market bifurcation, with Airfreight revenue surging 14% to $1.03B on favorable pricing while Ocean revenue plummeted 23% to $599M due to capacity oversupply pressuring both pricing and volumes. Management expects global capacity oversupply to persist near-term despite maintaining Ocean profitability. Customs/Other revenue jumped 17% to $1.15B, with double-digit growth across all products, due to hyperscaler and high-value technology customer demand plus tariff complexity. Operating margins reached the company's 30% target despite Middle East disruptions, with productivity gains from 2025 AI and technology investments beginning to materialize.

$EXPD
International

New Zealand's Jobless Rate Falls in March Quarter

New Zealand's seasonally-adjusted unemployment rate fell to 5.3% in the March quarter from 5.4% in the December 2025 quarter, data from Stats NZ showed on Wednesday.The seasonally-adjusted number of unemployed people for the quarter was 163,000, down from 165,000 for the December 2025 quarter.The underutilization rate was unchanged at nearly 13% in the quarter, while the participation rate slid 70.4% from 70.5% in the December 2025 quarter.The seasonally-adjusted employment rate was flat at about 67%.The seasonally adjusted youth not in employment, education, or training (NEET) rate rose to over 14% in the March quarter, up from over 13% in the December 2025 quarter."Women aged 20 to 24 continue to have the highest NEET rate, rising 1.9 percentage points to 20.3% in the March quarter," labor market spokesperson Abby Johnston said.

$^NZ50
Research

Research Alert: Emerson Electric: Fq2 Eps Beats Despite Sales Growth Slowdown

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:EMR delivered operating EPS growth of 4% Y/Y to $1.54, though underlying sales growth moderated to 0.5%, impacted by the U.S.-Iran conflict according to management. The beat was supported by share buyback activity. We see 5% underlying orders growth signaling a future recovery, with bookings centered in the high-margin Software & Systems business. Management expects Software segment profitability to enter modest recovery in 2H FY 26. The Software & Systems platform delivered 4% reported growth, with Test & Measurement achieving 16% reported growth, reflecting sustained demand in EMR's growth verticals including semiconductor and aerospace markets. Geographic performance revealed mixed fortunes, with Americas leading growth at 5% Y/Y, while Europe declined 4% and Asia/MEA fell 5%, reflecting broader geopolitical tensions. Adjusted segment EBITA margin compressed 40 bps Y/Y to 27.6% despite favorable mix shift toward higher-margin Software & Systems, with Software margins declining 250 bps to 29.2%.

$EMR